Top stories

View all news

21 December 2021

COVAX awarded 2021 North-South Prize for enhancing global equitable access to COVID-19 vaccines

Geneva, 21 December 2021 – The COVAX Facility has been awarded the 2021 North-South Prize of the Council of Europe in recognition of its efforts to ensure that COVID-19 vaccines are available worldwide, including in low-income countries, and for…

10 December 2021

Gavi and Moderna reach agreement for additional supply to COVAX

Agreement will make up to an additional 150 million doses of the Moderna COVID-19 vaccine available to COVAX Facility participants in Q2 and Q3 2022, at the lowest tiered price.

3 December 2021

Gavi Board approves malaria vaccine programme funding, COVAX 2022 strategic approach and measures to maintain, restore and strengthen routine immunisation

A new malaria vaccination programme has been approved, providing Gavi-eligible countries in sub-Saharan Africa a powerful new tool with which to fight malaria.

COVID-19 vaccine COVAX deliveries

>1 bn COVAX vaccines shipped
OWP
144 participants

As of 17 Jan 2022

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

The COVID-19 vaccine race

Pre-clinical
194vaccines
are being explored in lab experiments and animals
PHASE 1
38 vaccines
are undergoing safety tests in healthy young individuals
Phase 2
44vaccines
are being tested in broader groups of people
Phase 3
39vaccines
are in large international trials to test their impact on COVID-19
IN USE
23vaccines
are currently being offered to the general population
Phase 4
10vaccines
are being monitored in the wider population after being approved

Source: WHO

Learn more

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

#VaccinesWork

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

18 January 2022

The top 5 Omicron symptoms to be aware of

 As the Omicron variant of COVID-19 continues to spread around the world, here’s what you need to know about its symptoms.

18 January 2022

Infectious period: Are cuts to COVID-19 isolation times a good idea?

Growing numbers of countries are cutting the isolation period for people who test positive for COVID-19, but what does the science say about how long people remain infectious for?

18 January 2022

You need a plan: Successfully immunising zero-dose children in Nigeria

COVID-19 has hit routine immunisation hard in southern Nigeria. Authorities are now working hard to ensure children don’t miss out.

Supported countries

Supported Countries

Our impact

Syringe >888 million children immunised
First aid locator >15 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >230 US$ billion in economic benefits for countries (2000–2020)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter